Systematic Review of Complication Rates of Gender-affirming Breast Augmentation and Its Closest Analogue: Tuberous Breast Augmentation

对性别肯定隆胸术及其最接近的类似手术(管状隆胸术)并发症发生率的系统评价

阅读:2

Abstract

BACKGROUND: Gender-affirming breast augmentation (GABA) with implants is most commonly compared with cosmetic breast augmentation. A better comparator is tuberous breast augmentation (TBA). Anatomically, both feature relative medial pole deficiency, constricted breast footprints, and parenchymal herniation through the areola. Technically, both often require radial scoring and inframammary fold lowering. This review summarized techniques and outcomes of GABA and TBA. METHODS: A systematic review was performed in 3 databases: PubMed/MEDLINE, Scopus, and the Cochrane Database of Controlled Trials from 2000 to 2024. In total, 1319 articles were identified, of which 29 met inclusion criteria: outcomes-based primary literature detailing GABA and/or TBA. Meta-analysis was performed, but due to the noncomparative nature of the included studies, no comparative statistics were performed. RESULTS: In total, the GABA cohort included 3234 breasts in 1617 patients from 13 studies, and the TBA cohort featured 1093 breasts in 583 patients from 16 studies. Cohort characteristics were similar between groups. Surgical characteristics included primarily prepectoral augmentation via inframammary fold incision in the GABA cohort and dual-plane augmentation via periareolar incision in the TBA cohort. In both the GABA and TBA cohorts, rates of common complications, including explantation, infection, hematoma, and seroma, were all below 1%. The rate of reoperation was 4.5% in the GABA cohort and 11.9% in the TBA. CONCLUSIONS: This systematic review found low rates of complications in GABA and confirmed that GABA uses standard surgical techniques, which are routinely used in other breast procedures. Our findings demonstrate a similar complication profile between GABA and TBA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。